title: Ductal carcinoma in situ--management update.
abstract: This ninth article in our series on breast disease will focus on ductal carcinoma in situ of the breast--a proliferation of potentially malignant cells within the lumen of the ductal system. An overview of the management of ductal carcinoma in situ including pathology, clinical presentation and relevant investigations is presented, and the roles and dilemmas of surgery, radiotherapy and endocrine therapy are discussed.
authors.affiliation: NSW BReast Cancer Institute, Westmead Hospital, New South Wales.
authors.forename: Kirsty
authors.initials: K
authors.lastname: Stuart
authors.forename: John
authors.initials: J
authors.lastname: Boyages
authors.forename: Meagan
authors.initials: M
authors.lastname: Brennan
authors.forename: Owen
authors.initials: O
authors.lastname: Ung
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001365:Axilla; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D002114:Calcinosis / Q000000981:diagnostic imaging; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D008327:Mammography; D008408:Mastectomy / Q000379:methods; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D010348:Patient Care Team; D017410:Practice Guidelines as Topic; D011878:Radiotherapy / Q000379:methods
chemical_list: D018931:Antineoplastic Agents, Hormonal